Y-mAbs and Takeda Announces Marketing Authorization in Israel for DANYELZA® (naxitamab-gqgk) for Neuroblastoma PressReach · Aug 31, 2022
Illumina Genomics Forum to Feature Tennis Legend Chris Evert on the Role Genomics Played in her Cancer Fight PressReach · Aug 30, 2022
Cigna Grows ACA Marketplace Presence, Giving More Customers and Communities Access to Quality, Cost-Effective Care PressReach · Aug 29, 2022
Cardiff Oncology to Host Webcast and Conference Call to Provide a Clinical and Corporate Update on September 12, 2022 PressReach · Aug 29, 2022
Swissmedic Authorizes Moderna's Omicron-Targeting Bivalent Booster Candidate, MRNA-1273.214 PressReach · Aug 29, 2022
Zimmer Biomet to Present at Morgan Stanley 20th Annual Global Healthcare Conference and J.P. Morgan 13th Annual U.S. All Stars Conference PressReach · Aug 29, 2022
New REDUCE-IT® Data Show VASCEPA®/VAZKEPA® (icosapent ethyl) Reduced Cardiovascular Events in Patients Who Are Current or Former Smokers PressReach · Aug 28, 2022
New REDUCE-IT® Data Show VASCEPA®/VAZKEPA® (icosapent ethyl) Reduced STEMI as Well as Other MI Subtypes PressReach · Aug 26, 2022
Alma Raises $130M in Series D Funding led by Thoma Bravo to Advance its Mission to Simplify Access to High Quality, Affordable Mental Health Care PressReach · Aug 26, 2022